Biomarkers and Response to Natalizumab for Multiple Sclerosis Treatment

Clinical trial NCT00942214 · COMPLETED

Trial details

NCT number: NCT00942214
Sponsor: University Hospital, Toulouse
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2009-06-01
Primary completion: 2011-02-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.